Your browser is out-of-date!

Update your browser to view this website correctly.

1Cookies

2Disclaimer

Bellevue Entrepreneur Switzerland (CH)

ISIN-No.: CH0379353722

YTD: 1.05%

Active share: 44.88

Anzahl Positionen: 42

Explained in 90 seconds

Bellevue Entrepreneur Strategies explained in 90 seconds

Owner-operated or family-run companies think in generations, not in quarters 

Solid balance sheets, high innovative strength and safety awareness have a positive effect on the share price

Companies impress with high ESG scores

Indexed performance (as at: 10.04.2026)

NAV: CHF 159.60 (09.04.2026)


01 Jan 2010 - 01 Jan 2010
An error occurred - no data to display
B-CHF
Benchmark

Rolling performance (10.04.2026)

B-CHFBenchmark
09.04.2025 - 09.04.202631.26%30.14%
09.04.2024 - 09.04.2025-10.75%-7.81%
09.04.2023 - 09.04.2024-0.70%1.60%
09.04.2022 - 09.04.2023-3.54%-6.54%

Annualized performance (10.04.2026)

B-CHFBenchmark
1 year31.26%30.14%
3 years5.17%6.82%
5 years1.96%4.50%
Since Inception p.a.5.68%6.75%

Cumulative performance (10.04.2026)

B-CHFBenchmark
1M2.15%1.34%
YTD1.05%2.17%
1 year31.26%30.14%
3 years16.32%21.89%
5 years10.18%24.60%
Since Inception60.95%75.44%

Annual performance

B-CHFBenchmark
202517.88%16.92%
20241.40%3.83%
20238.23%6.53%
2022-24.89%-17.83%

Investment Focus

The fund actively invests in listed owner-managed companies in Switzerland where an entrepreneur or a founder family holds at least a 20% of a company’s voting rights. The qualities of these companies – a focused business model, fast decision-making processes and a strong corporate culture – go hand in hand with efficient innovation, high product quality and strong customer loyalty. The corresponding impact on the share price is demonstrably positive. The fund’s Management Team offers a wealth of experience in this investment segment and has built up an extensive network with executives throughout the sector. It pursues a fundamental, bottom-up approach in identifying the most attractive founder-controlled companies with a small, mid as well as large market capitalization while maintaining an investment portfolio of 35 to 45 stocks diversified by sub-sector and style (Value, GARP, Growth). The fund takes ESG factors into consideration while implementing the aforementioned investment objectives.Show moreShow less

Investment suitability & Risk

SRI

Low risk

High risk

The Fund’s investment objective is to generate attractive and competitive capital growth in the long term. It is therefore particularly suited to investors with an investment horizon of at least 5 years who want to enhance their portfolio diversification with investments in Swiss founder-controlled companies. The Fund displays the typical risks associated with equity investments.

General Information

Investment ManagerBellevue Asset Management AG
CustodianCACEIS Bank, Montrouge, Zurich Branch
Fund AdministratorCACEIS Bank, Montrouge, Zurich Branch
AuditorPriceWaterhouseCoopers
Launch date04.04.2006
Year end closing31. Dec
NAV CalculationDaily "Forward Pricing"
Cut of time15:00 CET
Management Fee1.25%
Subscription Fee (max.)5.00%
ISIN numberCH0379353722
Valor number37935372
BloombergPMBESWB SW

Legal Information

Legal formInvestment funds under Swiss law
SFDR categoryArticle 8
Redemption periodDaily

Key data (31.03.2026, base currency CHF)

Beta1.03
Volatility12.51
Tracking error3.50
Active share44.88
Correlation0.96
Sharpe ratio0.25
Information ratio-0.52
Jensen's alpha-2.10
No. of positions42

Top 10 positions

Sandoz
Galderma
Lindt & Sprüngli
VAT Group
Huber + Suhner
Helvetia Holding AG
Roche
Accelleron Industries
Sulzer
Flughafen Zürich
5.8%
4.1%
4.0%
4.0%
3.9%
3.7%
3.5%
3.1%
3.1%
2.7%

Market capitalization

0 - 1 bn
1 - 2 bn
2 - 5 bn
5 - 15 bn
15 - 20 bn
> 20 bn
Others
4.0%
15.4%
19.6%
26.7%
2.4%
26.3%
5.5%

Breakdown by sector

Industrials
Healthcare
Financials
Consumer Staples
IT
Consumer Discretion
Materials
Telecommunication Services
Cash
38.0%
20.6%
12.2%
9.2%
6.5%
3.7%
2.8%
1.6%
5.5%

Benefits

  • Above-average top line growth driven by high innovation and strong pricing power.
  • Higher operating margins on the back of high market share ("Champion in the niche") combined with good cost discipline.
  • More conservatively financed, lower debt exposure and a higher risk capacity compared to non-family businesses.
  • Multi-award-winning management team with a long and successful track record investing in owner-run firms.
  • Entrepreneurs for entrepreneurs – the Bellevue Group is itself an owner-run company with the majority of shares held by employees.

Risks

  • The fund actively invests in equities. Equities are subject to price fluctuations and so are also exposed to the risk of price losses.
  • Shares in smaller businesses are generally traded in lower volumes and are subject to bigger price fluctuations than larger enterprises.
  • The fund may invest a proportion of its assets in financial instruments that might under certain circumstances have a relatively low level of liquidity, which can in turn affect the fund’s liquidity.
  • Succession planning poses an additional risk for owner-run companies.
  • The fund may engage in derivatives transactions. The increased opportunities gained come with an increased risk of losses.

Swiss SMID Caps as measured by the SPIEX Index declined (-6.5%) in the month, outperforming the SMI (-7.6%). The drawdown was driven by the escalation of the Iran conflict, including the temporary closure of the Strait of Hormuz, triggering a sharp energy shock with oil prices exceeding USD 100/bbl. Central banks remained on hold during the month but with a clear hawkish bias given the risk of a supply side energy inflation shock. Towards month-end, first signs of de-escalation caused modest pullbacks in energy prices. The Eurozone Composite PMI edged down to 50.5 in March, signaling continued but slower expansion. Overall growth was dragged down by a sharp reduction in the service sector, while manufacturing proved resilient (51.6), with Germany hitting a 45-month high of 51.7. The procure.ch manufacturing PMI jumped to 53.3 from 47.4, well above expectations, signaling a clear return to expansion - the first since December 2022. From a sector perspective Utilities (+3.8%), Financials (-0.6%) and Real Estate (-0.7%) performed best while Industrials (-10.4%), Consumer Discretionary (-9.3%) and Information Technology (-8.4%) lagged the most.

Against this backdrop, the fund (B shares, CHF) declined -5.9%, outperforming the benchmark by 60 bp.

The main detractors during the month were Burckhardt Compression (-17.9%), Montana Aerospace (-17.1%) and Inficon (-16.8%). For Burckhardt Compression we understand the H2 order momentum (year end 31.3) did not improve a lot sequentially and customers have stayed cautious amid uncertainty in the Middle East. Despite short term turbulences, the backdrop is remains favourable to Burckhardt’s narrative of energy security, transition and infrastructure capex spending. Management expressed confidence in achieving the mid-term targets. Montana aerospace corrected massively amidst Airbus revising its production guidance. Despite the war in Iran, Montana reiterated its conservative guidance for 2026 and sees stable supply chains so far. However, 2027 guidance fell short of analysts’ expectations leading to negative EPS revisions. Inficon had pre-released 2025 revenue as well as EBIT. In the wake of the many actual uncertainties management’s 2026 revenue guidance was at the lower end of consensus expectations and the muted margin outlook was a damper despite sound activity and order intake in the semi space. We expect further updates in the coming quarters and remain positive.

The top three contributors were Aryzta (+11.8%), Gurit (+43.5%) and Polypeptide (+10.3%). Aryzta benefited from solid FY 2025 results, slightly above expectations, particularly at the free cash flow (FCF). It guided for low to mid-single digit (L-MSD) organic growth and EBITDA expansion. Gurit released encouraging 2025 results, highlighting improved profitability from a streamlined perimeter following the exit from the carbon fiber business. With guidance pointing to single digit revenue growth and margin expansion, 2026 is set to confirm the improving trends seen in H2. PolyPeptide reported very strong FY 2025 results, driven by a sharp profitability increase following the ramp-up of a key GLP-1 contract. For 2026, it guided for 20-25% revenue growth and mid- to high-teen margins, implying a 400-600bps improvement, which should support strong EPS growth.

The Middle East and Hormuz remain key uncertainties. The magnitude and duration of the conflict and its effect on the global economy remain difficult to assess, and markets are reacting sensitively in both directions. Following a sensitivity analysis of the portfolio, we implemented selective adjustments to balance the portfolio relative to energy prices and interest rate volatility. Overall, the fund performed relatively well and we could close the month with slight outperformance. Interestingly, SMID did not underperform in the draw down, despite higher exposure to industrials. Defensive sectors like healthcare, household & personal care (HPC) and food and beverage (F&B) did not provide shelter and the structural exposure of industrials names to themes like defence, sovereignty, energy transition, electrification etc. makes the segment potentially less cyclical.

Loading...

Show moreShow less

Ratings

    • Co-Lead Portfolio Manager

      Birgitte Olsen

      Birgitte Olsen, CFA, Head Entrepreneur Investments, joined Bellevue Asset Management in 2008. Prior to that, she was Deputy Head of Portfolio Management Equities Europe at Generali Investments in Cologne for more than nine years. She worked as a Fund Manager (DE and Scandinavia) at Vontobel Asset Management in Zurich in 1997 and 1998. Birgitte Olsen started her career in the financial industry in 1994 as a sell-side analyst at Bank am Bellevue covering the insurance and pharmaceutical sectors. She holds a degree in Finance and Accounting from the University of St. Gallen.
    • Co-Lead Portfolio Manager

      Laurent Picard

      Laurent Picard joined Bellevue Asset Management in 2018. Prior to that, he was an Financial consultant for start-ups in the internet/tech sector. From 2009 to 2016 he was a senior equity research analyst for media at Société Générale, having joined from UBS Warburg, where he was an equity analyst for IT Services and Software and a strategist specialized on the French markets. Laurent Picard graduated from Paris X University and ESSEC business school and holds a Master of Financial Techniques.
    • Portfolio Manager

      Eduardo Bravo

      Eduardo Bravo joined Bellevue Asset Management in 2025 as a portfolio manager within the Entrepreneur Investment team. Prior to that, he spent ten years at Alantra’s EQMC fund in Madrid, where he was responsible for the healthcare sector. Eduardo began his career as a Corporate Finance Junior Analyst at BNP Paribas. He holds a degree in Business Administration from CUNEF University in Madrid.
    1

    These insights might interest you